Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2021
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Remarks:
This is an in-vitro test which adheres to generally accepted in-vitro validity criteria

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2021
Report date:
2021

Materials and methods

Test guideline
Qualifier:
no guideline required
Principles of method if other than guideline:
The detailed method followed, is described in XCellR8 SOP L0064 "Neutral Red Uptake (NRU) Cytoxicity Test Using Human Dermal Fibroblasts in Xeno-Free Culture Conditions"
GLP compliance:
no
Test type:
other: In-vitro: Neutral Red Uptake (NRU) Cytoxicity Test Using Human Dermal Fibroblasts in Xeno-Free Culture Conditions

Test material

Constituent 1
Chemical structure
Reference substance name:
Glycerol tribenzoate
EC Number:
210-379-6
EC Name:
Glycerol tribenzoate
Cas Number:
614-33-5
Molecular formula:
C24H20O6
IUPAC Name:
1,3-bis(benzoyloxy)propan-2-yl benzoate
Test material form:
solid: flakes
Details on test material:
room temperature: off-white coloured flakes or granulate; > 80 °C: colourless to yellowish liquid
Batch no. 20118
CAS no. 614-33-5
Production date 28. Jul. 2020
Expiry date 15. Aug. 2022
Specific details on test material used for the study:
Batch: 20118
Purity: 98.1%
Expiry: 24 months from 07/2020

Test animals

Species:
other: Human Dermal Fibroblast Cells
Strain:
other: Neonatal human dermal fibroblast cultures
Sex:
not specified

Administration / exposure

Route of administration:
other: A single application of 8 concentratons of the test item (n=6) was applied in cell culture medium with 1% DMSO (dilution factor of 2 in the range-finder, 1.3 in the main test).

Results and discussion

Preliminary study:
Cell viability did not reduce to below 50% at 200 ug/mL.
Effect levels
Key result
Sex:
not specified
Dose descriptor:
other: IC50
Effect level:
> 500 other: ug/mL
Based on:
test mat.
Remarks on result:
other: Based on cell viability

Applicant's summary and conclusion

Conclusions:
Glycerol tribenzoate was classified as Category 4 or Category 5 or Unclassified (Classification, IC50>500 ug/mL)